The global spinal cord stimulation devices market size is expected to reach USD 4.66 billion by 2030, expanding at a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of failed back syndrome and complex regional pain syndrome is anticipated to boost the market growth. Failed back syndrome occurs as a chronic pain after spinal surgeries for back or leg pain. After spinal surgery, the pain gets reduced or the condition may get worst due to scar tissue which build up around the spinal nerve roots.

Spinal cord stimulation device is used to treat patients who failed to get the result from spinal surgeries, by blocking the pain before it reaches the brain. Thus, increasing number of patients suffering from chronic pain after surgeries is likely to augment the product demand over the forecast period. In addition, technological advancements are expected to fuel the market growth further. For instance, Medtronic’s Intellis is a smallest implantable spinal cord stimulator designed to overcome limitations with the current systems.

The high dose therapy of the device helps reduce the pain for the patients suffering from diseases, such as degenerative disk disease. Key companies are introducing technologically enhanced products to gain competitive advantage in the industry. For instance, in January 2019, Boston Scientific launched its Spectra WaveWriter spinal cord stimulator in Europe. It is used for the treatment of chronic pain through electrical impulses. This new system also allows physicians and patients to customize their therapy.

Spinal Cord Stimulation Devices Market Report Highlights

• Rechargeable device segment led the global market in 2023 and is projected to expand further at the fastest CAGR from 2024 to 2030.
• This is attributed to the factors, such as new product launches by key companies and increasing number of patients suffering from neuropathic pain.
• Failed back syndrome was the dominant application segment in 2023 owing to high number of patients suffering from pain after spinal surgeries.
• North America led the global spinal cord stimulation devices market in 2023 owing to the increased incidence of post-laminectomy syndrome followed by chronic long standing back pain.

Spinal Cord Stimulation Devices Market Segmentation

Grand View Research has segmented the global spinal cord stimulation devices market based on product, application, and region:

Spinal Cord Stimulation Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Rechargeable
• Non-rechargeable

Spinal Cord Stimulation Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Failed Back Syndrome
• Complex Regional Pain Syndrome
• Degenerative Disk Disease
• Unsuccessful Disk Surgery
• Others

Spinal Cord Stimulation Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

List of Key Players in Spinal Cord Stimulation Devices Market

• Boston Scientific Corporation
• Medtronic
• NeuroSigma, Inc.
• Nevro Corp.
• Synapse Biomedical Inc
• Abbott
• GIMER MEDICAL
• PatSnap
• Cirtec
• Bluewind Medical

Order a free sample PDF of the Spinal Cord Stimulation Devices Market Intelligence Study, published by Grand View Research.